USPTO serial 99900128
SPI PHARMA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- —
- Law office
- —
What this means
Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies. Wait for assignment and the first examiner action. Monitor TSDR monthly for status changes to 638 (assigned) or an office action.
Need help with SPI PHARMA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Wilmington, DE, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
William C Wright
William C Wright EPSTEIN DRANGEL6 East 45th Street, 7th FloorNew York, NY 10017United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Excipients for use in the manufacture of pharmaceutical preparations; Excipients for use in the manufacture of pharmaceuticals; Excipients for use in the manufacture of veterinary preparations; Excipients for use in the manufacture of dietary supplements; Excipients for use in the manufacture of nutraceuticals; Excipients for use in the manufacture of food and beverages; Excipients for use in the manufacture of pharmaceuticals, veterinary preparations, dietary supplements, nutraceuticals, food and beverages; Active chemical ingredients for use in the manufacture of pharmaceuticals; Active chemical ingredients for use in the manufacture of pharmaceuticals for treating cardiovascular diseases, metabolic diseases, allergies and allergy diseases, arthritis, dermatological diseases, inflammatory diseases, eye diseases, pulmonary diseases, cancer, central nervous system disorders, amyotrophic lateral sclerosis, infectious diseases, gastrointestinal diseases and urologic diseases; Chemical additives for use in the manufacture of pharmaceuticals; Chemical additives for use in the manufacture of food and beverages; Chemical additives for use in the manufacture of pharmaceuticals, veterinary preparations, dietary supplements, nutraceuticals, food and beverages; Chemical preparations for use in the manufacture of pharmaceuticals, veterinary preparations, dietary supplements, nutraceuticals, food and beverages; Chemicals, namely, lactulose; Aluminium hydroxide; Magnesium hydroxide; Magnesium carbonate; Calcium carbonate | ACTIVE | — |
| 005 | Vaccine adjuvants; Drug delivery agents in the form of coatings for tablets, sweeteners, binders, and lubricants that facilitate the delivery of pharmaceutical preparations; Antacids; Aluminium acetate for pharmaceutical purposes; Dietary supplements consisting primarily of aluminum, magnesium, calcium; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Laxatives; Chemical reagents for veterinary purposes; Adjuvants for veterinary purposes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 23, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 23, 2026 | NWAP | NEW APPLICATION ENTERED | — |